Literatura científica selecionada sobre o tema "ECMO (médecine) – Complications (médecine)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "ECMO (médecine) – Complications (médecine)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "ECMO (médecine) – Complications (médecine)"
Dadon, Michel. "Médecine esthétique du visage et complications vasculaires". JMV-Journal de Médecine Vasculaire 47 (março de 2022): S39. http://dx.doi.org/10.1016/j.jdmv.2022.01.012.
Texto completo da fonteBouzidi, M., B. Arfaoui, S. Sayhi, N. Gueddiche, F. Ajili e N. Ben Abdelhfidh. "Corticoïdes et complications métaboliques en médecine interne". Annales d'Endocrinologie 84, n.º 5 (outubro de 2023): 609. http://dx.doi.org/10.1016/j.ando.2023.07.289.
Texto completo da fonteLe Guen, M., e T. Loeb. "Extracorporeal membrane oxygenation (ECMO) en médecine d’urgence : une technique non ordinaire pour des indications assez ordinaires". Journal Européen des Urgences et de Réanimation 27, n.º 4 (dezembro de 2015): 173–75. http://dx.doi.org/10.1016/j.jeurea.2015.10.006.
Texto completo da fonteRenouard, Franck, e Edith Perrault-Pierre. "Le comportement humain : première cause de complication en pratique médicale ?" L'Orthodontie Française 87, n.º 1 (março de 2016): 3–11. http://dx.doi.org/10.1051/orthodfr/2015037.
Texto completo da fonteSakarovitch, B., S. Monnier, R. Meckenstock, A. Therby, D. Khau e A. Greder-Belan. "Médecine interne et complications aiguës : comment mieux assister les services d’accueil des urgences ?" La Revue de Médecine Interne 35 (dezembro de 2014): A96—A97. http://dx.doi.org/10.1016/j.revmed.2014.10.155.
Texto completo da fonteBrousse, G. "Les nouvelles drogues de synthèse aux urgences : aspects épidémiologiques et cliniques, principes de prise en charge". European Psychiatry 30, S2 (novembro de 2015): S60. http://dx.doi.org/10.1016/j.eurpsy.2015.09.166.
Texto completo da fonteMESSAADI, N., S. CHALLOUT, C. VINCENT, M. BUBROVSKY, S. DUHEM, CL CHARREL, L. ZERHOUI e S. BAYEN. "Proportion d’élèves susceptibles d’être victimes de harcèlement scolaire consultant en médecine générale. Protocole de recherche". EXERCER 35, n.º 203 (1 de maio de 2024): 206–11. http://dx.doi.org/10.56746/exercer.2024.203.206.
Texto completo da fonteNahon, S. "Prise en charge des patients ayant une maladie inflammatoire chronique de l’intestin hospitalisés en médecine intensive et réanimation". Médecine Intensive Réanimation 27, n.º 4 (22 de junho de 2018): 309–16. http://dx.doi.org/10.3166/rea-2018-0045.
Texto completo da fonteKepka, S., T. Marx e T. Desmettre. "Le drainage thoracique aux urgences dans la prise en charge d’un épanchement pleural non traumatique". Annales françaises de médecine d’urgence 9, n.º 4 (julho de 2019): 261–68. http://dx.doi.org/10.3166/afmu-2019-0178.
Texto completo da fonteEmery, C., F. Lançon, F. Fagnani, M. Pechevis, I. Durand e D. Floret. "Prise en charge de la varicelle et de ses complications en médecine ambulatoire en France : l'étude ENVOL". Médecine et Maladies Infectieuses 36, n.º 2 (fevereiro de 2006): 92–98. http://dx.doi.org/10.1016/j.medmal.2005.12.001.
Texto completo da fonteTeses / dissertações sobre o assunto "ECMO (médecine) – Complications (médecine)"
Moussa, Mouhamed Djahoum. "Déterminants cliniques, physiopathologiques et pronostics associés aux complications liées à l’hémostase au cours des assistances circulatoires de courte durée à pompe centrifuge". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS055.
Texto completo da fonteThe purpose of this dissertation is to characterize hemostasis-related complications in patients supported by peripheral VA-ECMO to improve their prevention and to optimize the antithrombotic therapeutic approaches in use. In a first study, we qualitatively and quantitatively described the composition of thrombi collected from the VA-ECMO circuits. We observed that these thrombi are mainly made of VWF, fibrin and in a lesser proportion of platelets and RBCs. Our quantitative approach also allowed us to demonstrate the presence of NETs while there was no active septic, confirming the possibility of aseptic NETosis under VA-ECMO. By hierarchical cluster analysis, we identified 2 types of thrombi, each of which may be related to a different mechanism of formation. In this study, the location of thrombi on the VA-ECMO circuit did not impact their compositions, highlighting the heterogeneity of thrombi formed within VA-ECMO and the multifactorial mechanisms that support thrombosis in this setting. In a second study, we compared the performance of surface coatings on VA-ECMO circuits to reduce thrombinoformation and its clinical consequences. Two of the most used coatings in daily practice were compared: the phosphorylcholin-based coating and the polysaccharide-albumin-based coating. We observed a higher rate of thrombotic complications in the phosphorylcholin group without any excess bleeding events or mortality in either group. In addition, compared with thrombi from phosphorylcholin-coated circuit junctions, those from polysaccharide-albumin-coated circuits were poorer in VWF. Our work suggests that the level of anticoagulation should be modulated according to the type of coating of the ECMO circuit.The aim of our third study was to identify the most relevant bleeding events that may guide clinical decision-making for more aggressive clinical management and a greater investment in research. To this end, we compared the association between 3 bleeding classifications with 28-day mortality. The ELSO definition already in use and the BARC classification classes ≥ type 2 were associated with 28-day mortality and thus retained as definitions of major bleeding. Laboratory parameters that are predictors major bleeding according to the ELSO definition were decreased fibrinogen, platelet count, and hemoglobin at cannulations. Body mass index and postcardiotomy etiology were also predictive of ELSO major bleeding. In an additional work related to the topic of the thesis, we studied two of the most used laboratory tests for the monitoring of systemic heparin during VA-ECMO, the APTT and the Anti-Xa activity, to identify the most relevant. First, we studied the relationship between these two tests and then analyzed in a second objective the impact of biological influencing factors on this relationship. Next, we determined their associations with thrombotic and hemorrhagic complications. Although linearly associated, the rate of discordance between their measurements was 39 % for an Anti-Xa reference range of 0.3 - 0.7 IU/mL. Neither APTT nor Anti-Xa was associated with thrombotic or bleeding complications. Taken together, our results highlight the heterogeneity of thrombi from peripheral VA-ECMO, the involvement of numerous causal factors that underline thrombotic and hemorrhagic complications, both not predictable by routine tests. Finally, our work underscored the need for new approaches in thrombotic or hemorrhagic complications management with targets set at an individual level considering both patient and ECMO circuit characteristics
Fernandez, Calahorra Francisco Javier. "Conversions et complications dans la cholecystectomie par laparoscopie : à propos d'une série consécutive de 393 opérés". Bordeaux 2, 1992. http://www.theses.fr/1992BOR23099.
Texto completo da fonteJoannes, Marie-Odile. "Recherche de polymorphysmes génétiques associés à des complications majeures de pathologies prédominantes en Martinique et en Guadeloupe : la drépanocytose et le diabète". Antilles-Guyane, 2009. http://www.theses.fr/2009AGUY0269.
Texto completo da fonteSICKLE CELL DISEASE (SCD) AND DIABETES MELLlTUS ARE LEADING CAUSES OF MORBIDITY IN MARTINIQUE AND GUADElOUPE. BECAUSE OF THE ASSOCIATION OF SOME GENETIC POLYMORPHISMS AND PATHOlOGIES, WE WONDERED IF SOME GENETIC POLYMORPHISMS COULD PREDICT COMPLICATIONS IN SICKLE CELL PATIENTS AND TYPE 2 DIABETIC WE INVESTIGATED POLYMORPHISM OF GENES INVOLVED IN THE IMMUNE SYSTEM (MYELOPEROXYDASE, HLA, TNF ALPHA, IFN GAMMA, IL6 AND IL10) AS MODULATORS OF INFECTIOUS COMPLICATIONS IN SCD. WE ALSO TRIED TO FIND AN ASSOCIATION BETWEEN FABP2 POLYMORPHISM, METABOLIC SYNDROME AND CARDIOVASCULAR COMPLICATIONS IN T2D SUBJECTS. OUR RESULTS REVEALED AN ASSOCIATION BETWEEN MYELOPEROXIDASE POLYMORPHISM AND INFECTIOUS COMPLICATIONS IN SICKLE CELL PATIENTS JUST AS IFNr POLYMORPHISM. ON THE OTHER HAND, HLA-DRB1*11 COULD HAVE A PROTECTIVE EFFECT AGAINST INFECTIONS. MOREOVER, OUR RESULTS HIGHLIGHTED A PREDOMINANT COMBINATION OF DYSLlPIDEMIA AND OBESITY IN T2D PATIENTS CARRYING THE THREONINE VARIANT OF FABP2
Gérard, Sonia. "Complications maternelles des césariennes". Rouen, 1990. http://www.theses.fr/1990ROUE104M.
Texto completo da fonteTiprez-Chocoloff, Catherine. "La reconstruction vasculaire après oxygénation extracorporelle en période néonatale : à propos de 26 observations". Lille 2, 1995. http://www.theses.fr/1995LIL2M105.
Texto completo da fonteCourtault, Carine. "Complications des fibrinolyses de thromboses de prothèses mécaniques de valves cardiaques". Bordeaux 2, 2001. http://www.theses.fr/2001BOR2M070.
Texto completo da fonteGayraud, Laurence. "Bronchiolite oblitérante au cours des transplantations pulmonaires et cardiopulmonaires : apport de la TDM-HR". Bordeaux 2, 1993. http://www.theses.fr/1993BOR23054.
Texto completo da fonteMeyrat, Léon. "Les complications graves des sinusites ethmoidales et frontales : place du traitement médical et chirurgical". Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M126.
Texto completo da fonteNarbey, Noëlle. "Rechute fébrile attribuée à une méningoencéphalite herpétique dans les suites d'un neuropaludisme : complication ou coincidence ? à propos d'un cas". Bordeaux 2, 1995. http://www.theses.fr/1995BOR2M100.
Texto completo da fonteGouget, Anne-Marie. "Le trouble somatisation". Bordeaux 2, 1997. http://www.theses.fr/1997BOR2M118.
Texto completo da fonteLivros sobre o assunto "ECMO (médecine) – Complications (médecine)"
Barron, William M. Médecine de la femme enceinte. Paris: Flammarion Médecine-Sciences, 1990.
Encontre o texto completo da fonteOlivennes, François. Tout ce qu'il faut savoir avant une grossesse. Paris: Marabout, 2013.
Encontre o texto completo da fonteJankowski, Janusz A. Z. Inflammation and Gastrointestinal Cancers. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.
Encontre o texto completo da fonteVincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Encontre o texto completo da fonteBeck, Leslie. The complete nutrition guide to menopause: Natural strategies to manage symptoms, control weight and stay healthy. Toronto: Penguin Canada, 2008.
Encontre o texto completo da fonteCook, Robin. Host. New York: G. P. Putnam's Sons, 2015.
Encontre o texto completo da fonteDelcourt, Marie. Stérilités mystérieuses & naissances maléfiques dans l'antiquité classique. Paris: Les belles lettres, 1986.
Encontre o texto completo da fonteVincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Encontre o texto completo da fonteMaté, Gabor. When the body says no: Exploring the stress-disease connection. Hoboken, N.J: J. Wiley, 2011.
Encontre o texto completo da fonteMaté, Gabor. When the body says no: The cost of hidden stress. Toronto: A.A. Knopf Canada, 2003.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "ECMO (médecine) – Complications (médecine)"
Santin, A., e B. Renaud. "Drépanocytose et complications aiguës". In Maladies rares en médecine d’urgence, 279–301. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_17.
Texto completo da fonteMouthon, L. "Traitements immunomodulateurs et complications spécifiques". In Maladies rares en médecine d’urgence, 43–64. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_4.
Texto completo da fonteMouthon, L. "Principaux immunosuppresseurs et complications spécifiques". In Maladies rares en médecine d’urgence, 65–87. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_5.
Texto completo da fonteArnulf, B. "Complications aiguës des syndromes lymphoprolifératifs". In Maladies rares en médecine d’urgence, 89–107. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_6.
Texto completo da fonteGuedj, M., e D. Monnet. "Complications ophtalmologiques aiguës des maladies systémiques". In Maladies rares en médecine d’urgence, 221–39. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_14.
Texto completo da fonteBerezne, A., G. Bussone e L. Mouthon. "Complications aiguës de la sclérodermie systémique". In Maladies rares en médecine d’urgence, 109–24. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_7.
Texto completo da fonteTerrier, B., e V. Le Guern. "Complications aiguës du lupus érythémateux systémique". In Maladies rares en médecine d’urgence, 125–37. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_8.
Texto completo da fonteCharles, P., e X. Puéchal. "Complications aiguës des vascularites associées aux ANCA". In Maladies rares en médecine d’urgence, 139–52. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_9.
Texto completo da fonteOlivier, Pierre-Yves, Julien Demiselle, Pierre Asfar, Alain Mercat e Nicolas Lerolle. "ECMO veino-veineuse et veino-artérielle : surveillance et complications". In Petit manuel de survie en médecine intensive-réanimation, 126–29. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77693-9.00037-x.
Texto completo da fonteVaillant, L. "Complications des Lymphœdèmes". In Traité de médecine vasculaire., 291–95. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-71346-0.50007-0.
Texto completo da fonte